Sanara MedTech (SMTI) Cash from Operations (2010 - 2026)

Sanara MedTech has reported Cash from Operations for 16 years, with the latest figure at 2465407.0 in Q1 2026.

• For the quarter ending Q1 2026, Cash from Operations fell 23.34% year-over-year to 2465407.0; the trailing twelve-month figure through Mar 2026 stood at 6320106.0 (up 1575.63% YoY), and the FY2025 full-year result was 6786629.0, up 28634.43% from the prior year.
• Cash from Operations for Q1 2026 stood at 2465407.0, down from 3945061.0 in the prior quarter.
• The five-year high for Cash from Operations was 3945061.0 in Q4 2025, with the low at 2465407.0 in Q1 2026.
• Historically, Cash from Operations has averaged 264881.65 across 5 years, with a median of 1154317.0 in 2022.
• Annual changes were most pronounced in 2022 — Cash from Operations plunged 245.3% — and 2025, when it soared 323.27%.
• Sanara MedTech's Cash from Operations stood at 645016.0 in 2022, then plunged by 31.55% to 848532.0 in 2023, then surged by 209.84% to 932047.0 in 2024, then soared by 323.27% to 3945061.0 in 2025, then tumbled by 162.49% to 2465407.0 in 2026.
• The last three Cash from Operations figures came in at 2465407.0 (Q1 2026), 3945061.0 (Q4 2025), and 2176441.0 (Q3 2025), per Business Quant data.